ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

MDC Mediclinic International Plc

501.00
0.00 (0.00%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Mediclinic International Plc LSE:MDC London Ordinary Share GB00B8HX8Z88 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 501.00 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Mediclinic International plc Director/PDMR Shareholding (3423H)

06/06/2017 5:42pm

UK Regulatory


Mediclinic (LSE:MDC)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Mediclinic Charts.

TIDMMDC

RNS Number : 3423H

Mediclinic International plc

06 June 2017

Mediclinic International plc

(Incorporated in England and Wales)

Company Number: 08338604

LSE Share Code: MDC

JSE Share Code: MEI

NSX Share Code: MEP

ISIN: GB00B8HX8Z88

LEI: 2138002S5BSBIZTD5I60

("Mediclinic", the "Company" or the "Group")

6 June 2017

NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

Vesting of awards under the Company's Forfeitable Share Plan

The awards of ordinary shares in Mediclinic (the "Shares") set out in the table below, granted on 31 July 2014, vested under the Company's Forfeitable Share Plan on 31 May 2017.

 
 Name                   Director/      Number       Number         Number 
                         PDMR         of Shares    of Shares      of Shares 
                                       vested       sold at      retained(1) 
                                                   ZAR 130.44 
                                                   per share 
---------------------  -----------  -----------  ------------  ------------- 
 Danie Meintjes         Director         49,423             0         49,423 
---------------------  -----------  -----------  ------------  ------------- 
 Gert Hattingh          PDMR             14,734             0         14,734 
---------------------  -----------  -----------  ------------  ------------- 
 Koert Pretorius        PDMR             19,806        19,806              0 
---------------------  -----------  -----------  ------------  ------------- 
 David Hadley           PDMR              9,778         9,778              0 
---------------------  -----------  -----------  ------------  ------------- 
 Dr Ole Wiesinger(1)    PDMR             17,506             0         17,506 
---------------------  -----------  -----------  ------------  ------------- 
 Dr Ronnie 
  van der Merwe         PDMR             16,507        16,507              0 
---------------------  -----------  -----------  ------------  ------------- 
 

1. Dr Wiesinger was granted a conditional right to 17,506 Shares under the Country Schedule to the Forfeitable Share Plan on 31 July 2014. On 1 June 2017, Dr Wiesinger elected to receive the award in Shares, which he received on 5 June 2017.

The following notification made in accordance with Articles 19.1 and 19.3 of the Market Abuse Regulation relates to the Company's Forfeitable Share Plan.

 
 1.   Details of PDMR / person closely associated 
       with them ("PCA") 
---  ------------------------------------------------------------- 
 a)   Name                   Daniël Petrus Meintjes 
---  ---------------------  -------------------------------------- 
 2.   Reason for the notification 
---  ------------------------------------------------------------- 
 a)   Position               Chief Executive Officer of the 
       / status               Company 
---  ---------------------  -------------------------------------- 
 b)   Initial notification   Initial Notification 
       / amendment 
---  ---------------------  -------------------------------------- 
 3.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
---  ------------------------------------------------------------- 
 a)   Name                   Mediclinic International plc 
---  ---------------------  -------------------------------------- 
 b)   LEI                    2138002S5BSBIZTD5I60 
---  ---------------------  -------------------------------------- 
 4.   Details of the transaction(s): section to 
       be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  ------------------------------------------------------------- 
 a)   Description            Ordinary Shares 
       of the financial 
       instrument             GB00B8HX8Z88 
       Identification 
       Code 
---  ---------------------  -------------------------------------- 
 b)   Nature of              Vesting of award over 49,423 ordinary 
       the transaction        shares awarded under the Company's 
                              Forfeitable Share Plan 
---  ---------------------  -------------------------------------- 
 c)   Price(s)                 Price(s)    Volume(s) 
       and volume(s)           ----------  ---------- 
                                Nil cost    49,423 
                               ----------  ---------- 
---  ---------------------  -------------------------------------- 
 d)   Aggregated 
       information 
       Aggregated 
       volume                  49,423 
       Price 
                               Nil cost 
---  ---------------------  -------------------------------------- 
 e)   Date of the            1 June 2017 
       transaction 
---  ---------------------  -------------------------------------- 
 f)   Place of               Johannesburg Stock Exchange 
       the transaction 
---  ---------------------  -------------------------------------- 
 
 
 1.   Details of PDMR / person closely associated 
       with them ("PCA") 
---  ------------------------------------------------------------- 
 a)   Name                   Gert C Hattingh 
---  ---------------------  -------------------------------------- 
 2.   Reason for the notification 
---  ------------------------------------------------------------- 
 a)   Position               Chief Corporate Services Officer 
       / status               of the Company 
---  ---------------------  -------------------------------------- 
 b)   Initial notification   Initial Notification 
       / amendment 
---  ---------------------  -------------------------------------- 
 3.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
---  ------------------------------------------------------------- 
 a)   Name                   Mediclinic International plc 
---  ---------------------  -------------------------------------- 
 b)   LEI                    2138002S5BSBIZTD5I60 
---  ---------------------  -------------------------------------- 
 4.   Details of the transaction(s): section to 
       be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  ------------------------------------------------------------- 
 a)   Description            Ordinary Shares 
       of the financial 
       instrument             GB00B8HX8Z88 
       Identification 
       Code 
---  ---------------------  -------------------------------------- 
 b)   Nature of              Vesting of award over 14,734 ordinary 
       the transaction        shares awarded under the Company's 
                              Forfeitable Share Plan 
---  ---------------------  -------------------------------------- 
 c)   Price(s)                 Price(s)    Volume(s) 
       and volume(s)           ----------  ---------- 
                                Nil cost    14,734 
                               ----------  ---------- 
---  ---------------------  -------------------------------------- 
 d)   Aggregated 
       information 
       Aggregated 
       volume                  14,734 
       Price 
                               Nil cost 
---  ---------------------  -------------------------------------- 
 e)   Date of the            1 June 2017 
       transaction 
---  ---------------------  -------------------------------------- 
 f)   Place of               Johannesburg Stock Exchange 
       the transaction 
---  ---------------------  -------------------------------------- 
 
 
 1.   Details of PDMR / person closely associated 
       with them ("PCA") 
---  ------------------------------------------------------------ 
 a)   Name                   Koert Hendrik S Pretorius 
---  ---------------------  ------------------------------------- 
 2.   Reason for the notification 
---  ------------------------------------------------------------ 
 a)   Position               Chief Executive Officer - Mediclinic 
       / status               Southern Africa 
---  ---------------------  ------------------------------------- 
 b)   Initial notification   Initial Notification 
       / amendment 
---  ---------------------  ------------------------------------- 
 3.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
---  ------------------------------------------------------------ 
 a)   Name                   Mediclinic International plc 
---  ---------------------  ------------------------------------- 
 b)   LEI                    2138002S5BSBIZTD5I60 
---  ---------------------  ------------------------------------- 
 4.   Details of the transaction(s): section to 
       be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  ------------------------------------------------------------ 
 a)   Description            Ordinary Shares 
       of the financial 
       instrument             GB00B8HX8Z88 
       Identification 
       Code 
---  ---------------------  ------------------------------------- 
 b)   Nature of              1. Vesting of award over 19,806 
       the transaction        ordinary shares awarded under 
                              the Company's Forfeitable Share 
                              Plan 
                              2. Sale of 19,806 ordinary shares. 
---  ---------------------  ------------------------------------- 
 c)   Price(s)                 Price(s)         Volume(s) 
       and volume(s)           ---------------  ---------- 
                                1. Nil cost      1. 19,806 
                               ---------------  ---------- 
                                2. ZAR 130.44    2. 19,806 
                               ---------------  ---------- 
---  ---------------------  ------------------------------------- 
 d)   Aggregated              1. 19,806 
       information 
       Aggregated              2. 19,806 
        volume 
       Price                   1. Nil cost 
                               2. ZAR 130.44 
---  ---------------------  ------------------------------------- 
 e)   Date of the            1 June 2017 
       transaction 
---  ---------------------  ------------------------------------- 
 f)   Place of               Johannesburg Stock Exchange 
       the transaction 
---  ---------------------  ------------------------------------- 
 
 
 1.   Details of PDMR / person closely associated 
       with them ("PCA") 
---  ------------------------------------------------------------ 
 a)   Name                   David J Hadley 
---  ---------------------  ------------------------------------- 
 2.   Reason for the notification 
---  ------------------------------------------------------------ 
 a)   Position               Chief Executive Officer - Mediclinic 
       / status               Middle East 
---  ---------------------  ------------------------------------- 
 b)   Initial notification   Initial Notification 
       / amendment 
---  ---------------------  ------------------------------------- 
 3.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
---  ------------------------------------------------------------ 
 a)   Name                   Mediclinic International plc 
---  ---------------------  ------------------------------------- 
 b)   LEI                    2138002S5BSBIZTD5I60 
---  ---------------------  ------------------------------------- 
 4.   Details of the transaction(s): section to 
       be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  ------------------------------------------------------------ 
 a)   Description            Ordinary Shares 
       of the financial 
       instrument             GB00B8HX8Z88 
       Identification 
       Code 
---  ---------------------  ------------------------------------- 
 b)   Nature of              1. Vesting of award over 9,778 
       the transaction        ordinary shares awarded under 
                              the Company's Forfeitable Share 
                              Plan 
                              2. Sale of 9,778 ordinary shares. 
---  ---------------------  ------------------------------------- 
 c)   Price(s)                 Price(s)         Volume(s) 
       and volume(s)           ---------------  ---------- 
                                1. Nil cost      1. 9,778 
                               ---------------  ---------- 
                                2. ZAR 130.44    2. 9,778 
                               ---------------  ---------- 
---  ---------------------  ------------------------------------- 
 d)   Aggregated              1. 9,778 
       information 
       Aggregated              2. 9,778 
        volume 
       Price                   1. Nil cost 
                               2. ZAR 130.44 
---  ---------------------  ------------------------------------- 
 e)   Date of the            1 June 2017 
       transaction 
---  ---------------------  ------------------------------------- 
 f)   Place of               Johannesburg Stock Exchange 
       the transaction 
---  ---------------------  ------------------------------------- 
 
 
 1.   Details of PDMR / person closely associated 
       with them ("PCA") 
---  ------------------------------------------------------------ 
 a)   Name                   Dr Thorsten Ole Wiesinger 
---  ---------------------  ------------------------------------- 
 2.   Reason for the notification 
---  ------------------------------------------------------------ 
 a)   Position               Chief Executive Officer - Hirslanden 
       / status 
---  ---------------------  ------------------------------------- 
 b)   Initial notification   Initial Notification 
       / amendment 
---  ---------------------  ------------------------------------- 
 3.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
---  ------------------------------------------------------------ 
 a)   Name                   Mediclinic International plc 
---  ---------------------  ------------------------------------- 
 b)   LEI                    2138002S5BSBIZTD5I60 
---  ---------------------  ------------------------------------- 
 4.   Details of the transaction(s): section to 
       be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  ------------------------------------------------------------ 
 a)   Description            Ordinary Shares 
       of the financial 
       instrument             GB00B8HX8Z88 
       Identification 
       Code 
---  ---------------------  ------------------------------------- 
 b)   Nature of              Vesting of conditional right to 
       the transaction        17,506 Shares under the Country 
                              Schedule to the Forfeitable Share 
                              Plan on 31 July 2014 
---  ---------------------  ------------------------------------- 
 c)   Price(s)                 Price(s)    Volume(s) 
       and volume(s)           ----------  ---------- 
                                Nil cost    17,506 
                               ----------  ---------- 
---  ---------------------  ------------------------------------- 
 d)   Aggregated              17,506 
       information             Nil cost 
       Aggregated 
       volume 
       Price 
---  ---------------------  ------------------------------------- 
 e)   Date of the            5 June 2017 
       transaction 
---  ---------------------  ------------------------------------- 
 f)   Place of               Johannesburg Stock Exchange 
       the transaction 
---  ---------------------  ------------------------------------- 
 
 
 1.   Details of PDMR / person closely associated 
       with them ("PCA") 
---  ----------------------------------------------------------- 
 a)   Name                   Dr Carel A van der Merwe 
---  ---------------------  ------------------------------------ 
 2.   Reason for the notification 
---  ----------------------------------------------------------- 
 a)   Position               Chief Clinical Officer of the 
       / status               Company 
---  ---------------------  ------------------------------------ 
 b)   Initial notification   Initial Notification 
       / amendment 
---  ---------------------  ------------------------------------ 
 3.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
---  ----------------------------------------------------------- 
 a)   Name                   Mediclinic International plc 
---  ---------------------  ------------------------------------ 
 b)   LEI                    2138002S5BSBIZTD5I60 
---  ---------------------  ------------------------------------ 
 4.   Details of the transaction(s): section to 
       be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  ----------------------------------------------------------- 
 a)   Description            Ordinary Shares 
       of the financial 
       instrument             GB00B8HX8Z88 
       Identification 
       Code 
---  ---------------------  ------------------------------------ 
 b)   Nature of              1. Vesting of award over 16,507 
       the transaction        ordinary shares awarded under 
                              the Company's Forfeitable Share 
                              Plan 
                              2. Sale of 16,507 ordinary shares. 
---  ---------------------  ------------------------------------ 
 c)   Price(s)                 Price(s)         Volume(s) 
       and volume(s)           ---------------  ---------- 
                                1. Nil cost      1. 16,507 
                               ---------------  ---------- 
                                2. ZAR 130.44    2. 16,507 
                               ---------------  ---------- 
---  ---------------------  ------------------------------------ 
 d)   Aggregated              1. 16,507 
       information 
       Aggregated              2. 16,507 
        volume 
       Price                   1. Nil cost 
                               2. ZAR 130.44 
---  ---------------------  ------------------------------------ 
 e)   Date of the            1 June 2017 
       transaction 
---  ---------------------  ------------------------------------ 
 f)   Place of               Johannesburg Stock Exchange 
       the transaction 
---  ---------------------  ------------------------------------ 
 

About Mediclinic International plc

Mediclinic is an international private healthcare group with operating platforms in Southern Africa (South Africa and Namibia), Switzerland and the United Arab Emirates. Its core purpose is to enhance the quality of life of patients by providing acute care, specialist-orientated, multi-disciplinary healthcare services. Mediclinic also holds a 29.9% interest in Spire Healthcare Group plc, a LSE listed and UK-based private healthcare group.

Mediclinic comprises 74 hospitals and 37 clinics. Mediclinic Southern Africa operates 49 hospitals and 2 day clinics throughout South Africa and 3 hospitals in Namibia with more than 8 000 inpatient beds in total; Hirslanden operates 16 private acute care facilities and 4 clinics in Switzerland with more than 1 600 inpatient beds; and Mediclinic Middle East operates 6 hospitals and 31 clinics with more than 700 inpatient beds in the United Arab Emirates.

During February 2016, the combination of the Company (previously named Al Noor Hospitals Group plc), with operations mainly in Abu Dhabi in the United Arab Emirates, and Mediclinic International Limited was completed. Mediclinic International Limited was a South African based international private healthcare group founded in 1983 and listed on the JSE, the South African stock exchange, since 1986, with operations in South Africa, Namibia, Switzerland and the United Arab Emirates (mainly in Dubai). The combination resulted in the renaming of the enlarged group to Mediclinic International plc.

Mediclinic has a primary listing on the Main Market of the LSE, with secondary listings on the JSE in South Africa and the NSX in Namibia.

For further information, please contact:

Capita Company Secretarial Services Limited

Victoria Dalby

+44 (0)207 954 9600

Investor Relations, Mediclinic International plc

James Arnold, Head of Investor Relations

ir@mediclinic.com

+44 (0)20 3786 8181

Media queries

FTI Consulting

Brett Pollard/Debbie Scott (UK)

+44 (0)20 3727 1000

Frank Ford (South Africa)

+27 (0)21 487 9000

Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom

Website: www.mediclinic.com

Corporate broker: Morgan Stanley & Co International plc

JSE sponsor: RAND MERCHANT BANK (A division of FirstRand Bank Limited)

NSX sponsor: Simonis Storm Securities (Pty) Ltd

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHBLGDLXXGBGRL

(END) Dow Jones Newswires

June 06, 2017 12:42 ET (16:42 GMT)

1 Year Mediclinic Chart

1 Year Mediclinic Chart

1 Month Mediclinic Chart

1 Month Mediclinic Chart

Your Recent History

Delayed Upgrade Clock